Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity
K Schoen, T Yu, C Stockmann, MG Spigarelli… - Pediatric Drugs, 2014 - Springer
Apnea of prematurity (AOP) is a common complication of preterm birth, which affects more
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity
K Schoen, T Yu, C Stockmann, MG Spigarelli… - Pediatric …, 2014 - search.proquest.com
Apnea of prematurity (AOP) is a common complication of preterm birth, which affects more
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity
K Schoen, C Stockmann… - Pediatric …, 2014 - corescholar.libraries.wright.edu
Apnea of prematurity (AOP) is a common complication of preterm birth, which affects more
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity
K Schoen, T Yu, C Stockmann… - Paediatric …, 2014 - pubmed.ncbi.nlm.nih.gov
Apnea of prematurity (AOP) is a common complication of preterm birth, which affects more
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity
K Schoen, T Yu, C Stockmann, MG Spigarelli… - Pediatric Drugs, 2014 - infona.pl
Apnea of prematurity (AOP) is a common complication of preterm birth, which affects more
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
K Schoen, T Yu, C Stockmann, MG Spigarelli… - Paediatric …, 2014 - europepmc.org
Apnea of prematurity (AOP) is a common complication of preterm birth, which affects more
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
[引用][C] Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity
K Schoen, T Yu, C Stockmann, MG Spigarelli… - Pediatric Drugs, 2014 - cir.nii.ac.jp
Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[HTML][HTML] Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity
K Schoen, T Yu, C Stockmann, MG Spigarelli… - Paediatric …, 2014 - ncbi.nlm.nih.gov
Apnea of prematurity (AOP) is a common complication of preterm birth, which affects more
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …
than 80% of neonates with a birth weight less than 1,000 g. Methylxanthine therapies …